Cleerly Announces CERTAIN Multicenter Clinical Trial Results
Study Results Demonstrate the Prominent Effects of Cleerly’s Products on Changing Clinical Management for Patients Suspected of Coronary Artery...
Study Results Demonstrate the Prominent Effects of Cleerly’s Products on Changing Clinical Management for Patients Suspected of Coronary Artery...
FDA cleared, evidence-based AI and machine learning-based algorithm detects heart disease-associated ischemia
Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 Data from...
Cleerly joins American Heart Association Center for Health Technology & Innovation Innovators’ Network American Heart Association consortium advances...
Learn more about Cleerly's AI-enabled technology that identifies the presence, type, and amount of heart disease which improves understanding of heart attack risk, and empowers clinicians to personalize treatment for better outcomes.
<div style="padding:56.25% 0 0 0; position:relative;"><iframe src="https://player.vimeo.com/video/708877726?h=61fd91e16c&badge=0&autopause=0&player_id=0&app_id=58479" frameborder="0" allow="autoplay; fullscreen; picture-in-picture" allowfullscreen style="position:absolute; top:0;left:0; width:100%; height:100%;" title="Cleerly / Beats"></iframe></div><script src="https://player.vimeo.com/api/player.js"></script>